MIT Startup Exchange is convening its seventh installment of Demo Day on Wednesday, December 7 (12 PM – 1:15 PM ET). The event will feature several exciting industry-ready startups in brief lightning talks and Q&A.
This event is for ILP members. You can confirm your company's ILP membership here: https://ilp.mit.edu/search/members.
Program Manager, MIT Startup Exchange
Ariadna Rodenstein is a Program Manager at MIT Startup Exchange. She joined MIT Corporate Relations as an Events Leader in September 2019 and is responsible for designing and executing startup events, including content development, coaching and hosting, and logistics. Ms. Rodenstein works closely with the Industrial Liaison Program (ILP) in promoting collaboration and partnerships between MIT-connected startups and industry, as well as with other areas around the MIT innovation ecosystem and beyond.
Prior to working for MIT Corporate Relations, she worked for over a decade at Credit Suisse Group in New York and London, in a few different roles in event management and as Director of Client Strategy. Ms. Rodenstein has combined her experience in the private sector with work at non-profits as a Consultant and Development Director at New York Immigration Coalition, Immigrant Defense Project, and Americas Society/Council of the Americas. She also served as an Officer on the Board of Directors of the Riverside Clay Tennis Association in New York for several years. Additionally, she earned her B.A. in Political Science and Communications from New York University, with coursework at the Instituto Tecnológico y de Estudios Superiores de Monterrey in Mexico City, and her M.A. in Sociology from the City University of New York.
Co-Founder & CEO, 1s1 Energy
Dr. Sobek is an entrepreneur with prior experience founding two deep tech companies. Prior to 1s1 Energy, he was the Chief Commercial Officer at Kernel, a $100M startup working on noninvasive brain interfaces. He has co-authored over 35 patents. Dr. Sobek holds a B.S in Aeronautics & Astronautics, an M.S. in Mechanical Engineering, and a Ph.D. in Electrical Engineering, all from the Massachusetts Institute of Technology (MIT).
CEO, NONA Technologies
Crawford is an MBA Candidate at MIT. Together, with Nona co-founder Junghyo Yoon, Nona Technologies won the MIT Desalination competition in 2022. Previously, Bruce was a Product Development Senior Financial Analysts at Rivian, where he supoorted engineering in the development of revoltuionary adventure vehicles in preparation for global launch.
CEO, HomeRun IQ
Marc is the founder and CEO of HomeRun IQ, which delivers cloud-based financial tools for multi-unit properties and their provider partners. These data-powered tools improve property financials, reduce total costs, and mitigate risk.
Marc is a recognized industry thought leader. He is a select member of the Community Association Institute (CAI) Foundation Think Tank, which has been published in journals and presented to national audiences. Most recently, he was part of the Surfside industry task force shaping new policies and legislation.
Marc is a seasoned Silicon Valley executive delivering innovative solutions in complex markets for over 20 years across industry-leading companies. Marc holds an MBA from the MIT Sloan School, an MS in Mechanical Engineering from MIT, and a BS in Mechanical Engineering from the University of Michigan.
Fadel Adib is an Associate Professor in the MIT Media Lab and the Department of Electrical Engineering and Computer Science. He is the founding director of the Signal Kinetics group which invents wireless and sensor technologies for networking, health monitoring, robotics, and ocean IoT. He is also the founder & CEO of Cartesian Systems, a spinoff from his lab that focuses on mapping indoor environments using wireless signals. Adib was named by Technology Review as one of the world’s top 35 innovators under 35 and by Forbes as 30 under 30. His research on wireless sensing (X-Ray Vision) was recognized as one of the 50 ways MIT has transformed Computer Science, and his work on robotic perception (Finder of Lost Things) was named as one of the 103 Ways MIT is Making a Better World. Adib’s commercialized technologies have been used to monitor thousands of patients with Alzheimer’s, Parkinson’s, and COVID19, and he has had the honor to demo his work to President Obama at the White House. Adib is also the recipient of various awards including the NSF CAREER Award (2019), the ONR Young Investigator Award (2019), the ONR Early Career Grant (2020), the Google Faculty Research Award (2017), the Sloan Research Fellowship (2021), and the ACM SIGMOBILE Rockstar Award (2022), and his papers have won awards for best papers, demos, and highlights at premier academic venues including SIGCOMM, MobiCom, CHI, and Nature Electronics. Adib received his Bachelors from the American University of Beirut (2011) and his PhD from MIT (2016), where his thesis won the Sprowls award for Best Doctoral Dissertation at MIT and the ACM SIGMOBILE Doctoral Dissertation Award.
Vice President, Sales, VizSeek
Matt Judge has been in the business world in many capacities since 1985. Matt is a graduate of Indiana University and the Advertising Arts College. He joined VizSeek, founded by MIT grad Jamie Tan, in 2015, and has secured clients in many industries. Matt is a frequent conference speaker, a history and language nerd, and his work has taken him to more than 25 countries.
Co-Founder & CEO, DXLab
Ho-Jun completed his Medical Engineering/Medical Physics Ph. D. in the Harvard/MIT Division of Health Sciences and Technology, working on robotic technologies for automated patch clamp recordings in vivo. He received the B.S. and M.S. degrees in Electrical and Computer Engineering from Cornell and University of Illinois at Urbana-Champaign respectively. Now he works on novel treatment strategies for Alzheimer’s disease, working between the labs of Professor Li-Huei Tsai and Professor Ed Boyden, as a postdoctoral scholar.
Co-Founder and CSO, Decoy Therapeutics
Barbara brings 25 years of leadership experience in pharma and biotech to bear on new drug discovery. During her time at Bayer Pharma she helped establish a new oncology department, and served as project leader for sorafenib, approved for kidney and liver cancers. Successive leadership positions at Chiron, Millennium Pharmaceuticals and Takeda consolidated a very broad-based expertise in advancing large and small molecule projects to and through clinical trials. Barb has deep experience on clinical development teams and a solid understanding of what it takes to get a drug approved. Over her career Barb has built a host of teams, from large departments to small specialty groups, and now as a co-founder of the infectious disease startup Decoy Therapeutics. Barb is passionate about bringing a new anti-viral therapeutic peptide platform to bear on COVID-19 and future emerging and re-emerging viral pathogens.
Disclaimer: MIT Startup Exchange can make introductions that ideally provide open ended discussions in order to share mutual interests and potentially create common ground that incite the parties to collaborate. MIT Startup Exchange introductions may eventually lead to mutual partnerships, but that is not in any way guaranteed by MIT, MIT Corporate Relations, MIT Industrial Liaison Program (ILP) or MIT Startup Exchange, which takes no responsibility for these outcomes and no formal part in such discussions following our introduction. MIT Startup Exchange and its activities and events are not for purposes of soliciting investment or offering securities.